Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
IHH Healthcare Bhd's revenue for the
three
months ended in Mar. 2026 was RM6,553 Mil.
Its revenue for the trailing twelve months (TTM) ended in Mar. 2026 was RM26,004 Mil.
IHH Healthcare Bhd's Revenue per Share for the
three
months ended in Mar. 2026 was RM0.74.
Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was RM2.95.
Warning Sign:
IHH Healthcare Bhd revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of IHH Healthcare Bhd was 5.00% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 12.60% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 13.50% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 10.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 13 years, IHH Healthcare Bhd's highest 3-Year average Revenue per Share Growth Rate was 26.50% per year. The lowest was 1.20% per year. And the median was 12.50% per year.
IHH Healthcare Bhd (XKLS:5225) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
IHH Healthcare Bhd Revenue Related Terms
IHH Healthcare Bhd Revenue Historical Data
* Premium members only.
The historical data trend for IHH Healthcare Bhd's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, IHH Healthcare Bhd's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IHH Healthcare Bhd Revenue vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, IHH Healthcare Bhd's Revenue distribution charts can be found below:
* The bar in red indicates where IHH Healthcare Bhd's Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM26,004 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IHH Healthcare Bhd (XKLS:5225) has a Revenue of RM26,004 Mil as of Mar. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on IHH Healthcare Bhd and its competitors.
Is IHH Healthcare Bhd's Revenue too high?
IHH Healthcare Bhd's current Revenue is RM26,004 Mil. Overall, IHH Healthcare Bhd has a GF Score™ of 88/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does IHH Healthcare Bhd's Revenue compare to HCA and THC?
IHH Healthcare Bhd's Revenue of RM26,004 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Healthcare Providers & Services company?
A good Revenue depends on the Healthcare Providers & Services industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on IHH Healthcare Bhd and its competitors. IHH Healthcare Bhd's current Revenue is RM26,004 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IHH Healthcare Bhd stock overvalued right now?
Based on GuruFocus' analysis, IHH Healthcare Bhd (XKLS:5225) is currently considered Fairly Valued. The stock's GF Value™ is RM8.15, compared to a current price of RM8.30 — trading 1.8% above its estimated fair value. The current Revenue is RM26,004 Mil. IHH Healthcare Bhd's overall GF Score™ is 88/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For IHH Healthcare Bhd (XKLS:5225), the current Revenue is RM26,004 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IHH Healthcare Bhd (XKLS:5225) Overvalued in 2026?
Based on GuruFocus' analysis, IHH Healthcare Bhd stock appears to be overvalued.
The current stock price of RM8.30 is trading 1.8% above its estimated GF Value™ of RM8.15.
GuruFocus considers IHH Healthcare Bhd to be Fairly Valued.
Key valuation signals for XKLS:5225:
Revenue: RM26,004 Mil
GF Value™: RM8.15 vs. price of RM8.30 (1.8% above fair value)
No single metric tells the full story. See the XKLS:5225 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IHH Healthcare Bhd is an investment holding company. Through its subsidiaries, it is a healthcare services provider that operates a network of hospitals. It also provides ancillary services, which include diagnostic laboratories, imaging centers, ambulatory care, and medical education facilities. The company's reportable segments include Healthcare services, Laboratories services, and Management fees. The majority of its revenue is generated from the Healthcare services segment, which relates to contracts with patients in which performance obligations are to provide healthcare services. Geographically, the company derives maximum revenue from Turkiye and Europe, followed by Singapore, Malaysia, India, Greater China, and Others.
88GF Score
Get the complete analysis for XKLS:5225
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:5225 has been successfully added to your 
